Updated on 11 June 2012
The objective of the day long conference was to provide a forum to present and discuss the role of key stakeholders towards realizing India's potential in diagnostics especially molecular diagnostics. During the conference, the regulator and policymakers from the Department of Biotechnology and the DCGI deliberated along with industry experts and academicians on various issues associated with the industry. The stakeholders also deliberated on various trade & practices for promoting collaboration between academia, industry and healthcare professionals.
Growing at a CAGR of 19 per cent, the global molecular diagnostics market is expected to reach $15 billion by 2014.The fastest growing segment is infectious diseases, enjoying the status as the dominant segment with its 21 per cent market share. The next fastest growing segment is oncology testing, given the rising cases of cancer. The future growth is expected to come from genetic testing, blood screening testing and neurological testing.